Hochschulschrift
Investigating metabolic dependencies of acute myeloid leukaemia and state-of-the-art metabolomics development by NMR spectroscopy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
187 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Literaturverzeichnis: Seite 149-165
Johann Wolfgang Goethe-University Frankfurt am Main, Germany, Dissertation, 2021
The University of Birmingham, Birmingham, United Kingdom, Dissertation, 2021
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main, Birmingham
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Entstanden
- 2021
Ähnliche Objekte (12)
Identification of CDX2 targets in acute myeloid leukaemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Computational modeling of metabolite dependencies: From metabolomics data to biochemical networks
Computational modeling of metabolite dependencies : from metabolomics data to biochemical networks
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Identification of CDX2 targets in acute myeloid leukaemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Computational modeling of metabolite dependencies: From metabolomics data to biochemical networks
Computational modeling of metabolite dependencies : from metabolomics data to biochemical networks
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Identification of CDX2 targets in acute myeloid leukaemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Computational modeling of metabolite dependencies: From metabolomics data to biochemical networks
Computational modeling of metabolite dependencies : from metabolomics data to biochemical networks
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)